DAVIS MILLER: Open Payments
NPI 1104860758 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 12 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $922 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 1 | $174 |
| Abbott Laboratories | 1 | $163 |
| Kerecis Limited | 1 | $146 |
| Mirum Pharmaceuticals, Inc. | 1 | $135 |
| Axsome Therapeutics, Inc. | 1 | $123 |
| Amgen Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| SANOFI US SERVICES INC. | 1 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $99 |
Products named: Senza, FREESTYLE LIBRE 3, Kerecis SurgiClose, Livmarli, Auvelity, KRYSTEXXA, DUPIXENT, AYVAKIT.
Industry payments across TX — which companies pay providers there.
